Novartis Selects GSK’s Saynor As Next Sandoz CEO

Novartis
Novartis has handed the top job at Sandoz to GSK executive Richard Saynor • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

More from Generics Bulletin